Search the Newsreel

USANA Health Sciences Inc (USNA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for USANA Health Sciences Inc (USNA) by business segment and geographical region. As of April 6, FY2025, the company's revenue is primarily driven by USANA® Nutritionals and includes contributions from USANA Foods, Personal care and Skincare, Hiya …

Sanathan Textiles Q1 Results: Earnings call scheduled for Aug 4

Sanara Medtech Inc (SMTI) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Sanara Medtech Inc (SMTI), providing a breakdown of major shareholders including FA Sanara, L.L.C., Tall Pines Capital LLC, and BlackRock Institutional Trust Company, N.A. It also categorizes shareholders by type (e.g., corporation, individual investor) and presents institutional …

Sanara Medtech Inc (SMTI) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Sanara Medtech Inc (SMTI) concerning its dividend and stock split history. It states that the company has distributed a total of $0.00 in dividends over the past five years and indicates that there is no historical data available …

USNA|USANA Health Sciences Inc|Price:21.320|Chg%:+0.400

This article provides a financial overview of USANA Health Sciences Inc. (USNA), including its stock performance, market capitalization, P/E ratio, and upcoming earnings date. It details key financial indicators such as EPS, revenue, net profit, net margin, gross margin, and debt-to-asset ratio across various …

Levi & Korsinsky Notifies Sana Biotechnology, Inc. (SANA) Investors - Lead Plaintiff Deadline on May 20, 2025

Levi & Korsinsky is notifying investors of Sana Biotechnology, Inc. (NASDAQ:SANA) who suffered losses that a lead plaintiff deadline is approaching on May 20, 2025. The class action securities lawsuit alleges that Sana Biotechnology made false and misleading statements about its financial capacity, the …

Asana Inc (ASAN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

Sanara Medtech Inc (SMTI) Financial Health: Profitability & Balance Sheet Analysis

Sanara Medtech Inc (SMTI) currently holds a financial score of 7.31, ranking 117 out of 155 in the pharmaceuticals industry, indicating stable financial health and high operating efficiency. The company reported a significant year-over-year revenue increase of 18.62% to $27.80 million, and its net …

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a 167% Potential Upside in the Biotech Arena

Sana Biotechnology, Inc. (SANA) is a key player in the biotechnology sector, focusing on cell engineering for unmet medical needs like type 1 diabetes and oncology. Despite current unprofitability and negative financial metrics common in R&D-heavy biotech, analysts are optimistic, assigning 8 buy ratings …

Sana Biotechnology, Inc. Revenue Breakdown – NASDAQ:SANA

ASAN|Asana Inc|Price:9.140|Chg%:-0.730

USANA Health Sciences Inc (USNA) Institutional Confidence

The article analyzes the institutional confidence score for USANA Health Sciences Inc (USNA), which currently stands at 5.00, ranking it 39th out of 93 in the Food & Tobacco industry. The latest institutional shareholding proportion is 61.48%, marking a quarter-over-quarter increase of 2.68%. Richard …

Sanara Medtech Inc (SMTI) Institutional Confidence

Sanara Medtech Inc (SMTI) currently holds an institutional shareholding score of 3.00, placing it 92nd out of 155 companies in the Pharmaceuticals industry. The institutional shareholding proportion has increased by 18.63% quarter-over-quarter to 15.50%. James Simons is the largest institutional shareholder, holding 0.71% of …

Sana Biotechnology Inc SANA Price:3.215 Chg%:+0.095

This article provides a detailed financial overview of Sana Biotechnology Inc (SANA), including its current stock price, market capitalization, key figures, and year-to-date performance. It highlights analyst ratings, which show a strong "Buy" consensus with a significant upside, and lists major shareholders. The company's …

ASAN|Asana Inc|Price:6.776|Chg%:+0.206

Asana Inc. (ASAN) is currently priced at $6.865, up 4.49%, with a market capitalization of $1.63 billion. Analysts rate the stock as "Hold" with a target price of $9.49. Despite strong fundamentals and revenue growth, the stock is considered fairly valued and trading sideways, …

Asana (ASAN) Loses Chief Accounting Officer, Is The Stock Still Trading At A Discount?

USANA Health Sciences Renews Four-Year Partnership with Nordiq Canada,

USANA Health Sciences has renewed its partnership with Nordiq Canada for another four years, extending through the 2030 Olympic Winter Games. As the official nutritional product supplier, USANA will provide its NSF Certified for Sport® products to support Nordiq Canada's elite cross-country ski athletes. …

REEDER TEKNOLOJI - KAP Haberleri - 2026-07-22 tarihli

Asana, Inc. (ASAN) Stock Price, News, Quote & History

This article provides a comprehensive overview of Asana, Inc. (ASAN), including its current stock price, financial statistics, news, and historical data. It details the company's work management software platform, its various products like AI Teammates and Asana AI Studio, and its go-to-market strategy. The …

Sana Biotechnology (SANA) Jefferies Global Healthcare Conference 2026 Summary

Sana Biotechnology presented at the Jefferies Global Healthcare Conference 2026, highlighting their hypoimmune allogeneic cell therapy and in vivo gene delivery platforms, both nearing clinical trials. The company aims for a functional cure for type 1 diabetes, focusing on immune evasion and insulin independence. …

Sanara MedTech stock trades steady as advanced wound care growth supports valuation

Sanara MedTech (SMTI) stock trades steadily, backed by robust growth in the advanced wound care sector. The company focuses on specialized products for surgical and chronic wound management within the U.S. healthcare market, showing consistent double-digit revenue expansion and strategic investments in sales and …

Asana (ASAN) Upgraded to Buy: Here's What You Should Know

Investors might want to bet on Asana, Inc. (ASAN), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. …

Trading Systems Reacting to (SMTI) Volatility

This article from July 21, 2026, details how trading systems are reacting to volatility in Sanara Medtech Inc. (NASDAQ: SMTI). It highlights strong near and mid-term sentiment but a weak long-term outlook for the stock. The article provides specific institutional trading strategies, including position, …

Why USANA (USNA) Stock Is Up Today

USANA Health Sciences (USNA) stock rose 2.9% after announcing the renewal of its partnership with Nordiq Canada through the 2030 Olympic Winter Games. As the official nutrition partner, USANA will continue supplying NSF Certified for Sport® products to Canada's elite cross-country ski athletes, reinforcing …

USANA renews nutrition partnership with Nordiq Canada through 2030

USANA Health Sciences, Inc. has renewed its partnership with Nordiq Canada, extending its role as the official nutrition partner through the 2030 Olympic Winter Games. USANA will supply NSF Certified for Sport nutritional products to Nordiq Canada’s athletes. The company (NYSE:USNA) reported strong Q1 …

Canadian ski athletes get tested nutrition through 2030 Olympics

USANA Health Sciences has renewed its partnership with Nordiq Canada, extending its role as the official nutrition partner for Canada's elite cross-country ski athletes through the 2030 Olympic Winter Games. USANA will supply NSF Certified for Sport® nutritional products to support athlete performance and …

ANATOLIA TANI VE - KAP Haberleri - 2026-07-20 tarihli

USANA stock supported by steady earnings and direct-selling reach

USANA Health Sciences Inc. (USNA) stock is closely linked to its global direct-selling health and nutrition network. Recent financial reports highlight stable revenue, resilient margins, and continuous investment in product innovation and distributor networks. The company's business model relies on its independent distributor base …

ETFs Investing in Asana, Inc. Class A Stocks

This article lists ETFs that invest in Asana, Inc. Class A stocks, sorted by market value. It provides key details for each ETF, including market value, weight of Asana stock, issuer, management style, focus, expense ratio, AUM, price, change percentage, relative volume, and 3-year …

Asana (ASAN) finance chief Veronica Sosa to step down as principal accounting officer

Asana, Inc. announced that Veronica Sosa will resign from her roles as Chief Accounting Officer and Principal Accounting Officer, effective August 7, 2026. She tendered her resignation on July 13, 2026, and will remain in her positions until the effective date to ensure a …

Responsive Playbooks and the ASAN Inflection

This article provides an in-depth analysis of Asana Inc. Class A (NASDAQ: ASAN), highlighting strong near and mid-term sentiment but a weak long-term outlook. It identifies a significant risk-reward short setup and offers institutional trading strategies, including long, breakout, and short positions, based on …

Personal Care Q1 Earnings: USANA (NYSE:USNA) Simply the Best

YIBITAS YOZGAT I - KAP Haberleri - 2026-07-09 tarihli

KALEKIM KIMYEVI - KAP Haberleri - 2026-07-09 tarihli

KLIMASAN KLIMA - KAP Haberleri - 2026-07-04 tarihli

Sana Biotechnology Q1 2026 Earnings: Narrower-than-Expected Loss Drives 2% Stock Uptick - Downward Estimate Revision